Rapid detection of mutations in CSF-cfTNA with the Genexus Integrated Sequencer

被引：0

作者：

Srividya Arjuna

Mauli Shah

Antonio Dono

Luis Nunez-Rubiano

Pavel S. Pichardo-Rojas

Jay-Jiguang Zhu

Roy F. Riascos

Rajyalakshmi Luthra

Sinchita Roy-Chowdhuri

Dzifa Duose

Daniel H. Wang

Frederick F. Lang

Yoshua Esquenazi

Leomar Y. Ballester

机构：

[1] The University of Texas MD Anderson Cancer Center Houston,Department of Translational Molecular Pathology

[2] McGovern Medical School at UT Health,Vivian L. Smith Department of Neurosurgery

[3] McGovern Medical School at UT Health,Department of Diagnostic and Interventional Imaging

[4] Memorial Hermann Hospital-TMC,Department of Hematopathology

[5] The University of Texas MD Anderson Cancer Center at Houston,Department of Pathology

[6] The University of Texas MD Anderson Cancer Center Houston,Department of Neurosurgery

[7] The University of Texas MD Anderson Cancer Center Houston,Center for Precision Health, Vivian L. Smith Department of Neurosurgery

[8] The University of Texas Health Science Center at Houston,Neuropathology and Molecular Genetic Pathology, Department of Pathology

[9] The University of Texas MD Anderson Cancer Center Houston,undefined

来源：

Journal of Neuro-Oncology | 2024年 / 166卷

关键词：

CSF; ctDNA; cfDNA; Genexus; Liquid biopsy; Brain metastases; Lung cancer; Breast cancer; Cerebrospinal fluid;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：39 / 49

页数：10

共 21 条

[1]

Barnholtz-Sloan JS(2004)Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System J Clin Oncol 22 2865-2872

[2]

Schouten LJ(2002)Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma Cancer 94 2698-2705

[3]

Ali S(2021)Molecular profiles of brain metastases: a focus on heterogeneity Cancers 13 2645-88

[4]

Heitzer E(2019)Current and future perspectives of liquid biopsies in genomics-driven oncology Nat Rev Genet 20 71-6

[5]

De Mattos-Arruda L(2015)Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma Nat Commun 6 1-306

[6]

Pan C(2019)Molecular profiling of tumors of the brainstem by sequencing of CSF-derived circulating tumor DNA Acta Neuropathol 137 297-9709

[7]

Wang Y(2015)Detection of tumor-derived DNA in cerebrospinal fluid of patients with primary tumors of the brain and spinal cord Proc Natl Acad Sci USA 112 9704-522

[8]

Bettegowda C(2014)Detection of circulating tumor DNA in early- and late-stage human malignancies Sci Transl Med 6 24-6

[9]

Pan W(2015)Brain tumor mutations detected in cerebral spinal fluid Clin Chem 61 514-270

[10]

Takayasu T(2020)Cerebrospinal fluid ctDNA and metabolites are informative biomarkers for the evaluation of CNS germ cell tumors Sci Rep 10 14326-2415

← 1 2 3 →